HUANG DENNIS KARL (See Remarks) sold 8.1% of their position (3.23K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $215.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2022ACC: 0001209191-22-015815
Officer· See Remarks
Since Mar 2026
+35.67K
Net shares
Net buyer
$215.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
38.90K acquired · 3.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.23K
Price / share
$66.62
Trade value
$215.45K
% of position
8.1%
3/1/2022
40.15K→36.91K
Common Stock
Direct
Shares
+14K
Price / share
—
Trade value
—
% of position
37.8%
3/1/2022
37.04K→51.04K
Total
Net shares
+10.77K
Net value
-$215.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2022 | S · Sale | −3.23K | $66.62 | $215.45K | 8.1% | 40.15K | 36.91K |
| Common Stock Direct | 3/1/2022 | A · Award | +14K | — | — | 37.8% | 37.04K | 51.04K |
| Total | +10.77K | -$215.45K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
24.90K shares
Shares
+24.90K
Strike price
67.37
Held after
24.90K
Exercisable
—
3/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock24.90K shares | 3/1/2022 | A · Award | +24.90K | 67.37 | — | 24.90K |